OS Therapies Announces Positive Biomarker Data from Phase 2b Clinical Trial of OST-HER2

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary

OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq ...
Business Wire

Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million

SAN DIEGO--(BUSINESS WIRE)--Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein ...

Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

Serum Institute Of India

Get all latest & breaking news on Serum Institute Of India. Watch videos, top stories and articles on Serum Institute Of ...
EuropaWire

GSK Secures China Approval for Trelegy Ellipta in Asthma, Expanding Single Inhaler Triple Therapy Use

GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...